The cannabis oil opportunity is one of the most exciting verticals within the cannabis sector and we have been closely monitoring this burgeoning market.
Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (the “Company” or “Chemesis”), is pleased to announce that it has closed the previously announced debenture unit offering with strategic investors for aggregate gross proceeds to the Company of CDN $2,000,000 (the “Offering”).
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX | NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM), announced today its financial and operational results for the first quarter ended September 30, 2018.
Q1 2019 Financial and Operational Highlights
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company") today provided a Fundamental Change Notice, Notice of Right to Convert, Notice of Make-Whole Fundamental Change and Related Conversion Rate Adjustment, and Offer to Repurchase for Cash (the "Notice") to holders of its C$600,000,000 aggregate principal amount of 4.25% Convertible Senior Notes Due 2023 (the "Notes"), pursuant to the Indenture, dated June 20, 2018, among the Company, GLAS Trust Company LLC, as U.S.
Tree of Knowledge International Corp. (CSE: TOKI; OTC PINK: TRKWF) (the "Company" or "TOK") (formerly Courtland Capital Inc.) wishes to provide an update on a number of corporate and strategic matters as the landscape has evolved quickly since the Company's listing on the Canadian Securities Exchange at the beginning of summer earlier this year (July 9, 2018).
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today that they have been awarded a Processor provisional license by the Ohio Department of Commerce.
EVIO Inc. (http://cts.businesswire.com/ct/CT...) (“EVIO” or the “Company”), (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, announced that EVIO Canada’s Keystone L
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that its Aurora Sky ("Sky") facility has been granted its sales license by Health Canada, significantly increasing availability of both dried flower and derivative cannabis products across all cannabis markets the Company is targeting.